VELTASSA (patiromer) Patient Assistance Program

Don’t let the high cost of brand specialty hyperkalemia therapy disrupt your treatment. We help eligible patients access Veltassa (patiromer) for as little as $69.95 per month through the manufacturer’s Patient Assistance Program.

HIPAA Compliant

BBB Accredited

Secure Website

Key ​Takeaways:

What Is Veltassa Prescription Assistance Program?

The Veltassa Prescription Assistance Program is a manufacturer-sponsored initiative that provides Veltassa at little or no medication cost to qualifying patients based on income and insurance status. The program is designed for hyperkalemia patients who are uninsured or underinsured, as well as Medicare Part D beneficiaries.

Navigating the program on your own means dealing with eligibility verification, nephrology/cardiology/primary care coordination, prior-authorization documentation, specialty pharmacy logistics, and renewal deadlines.

AffordMyPrescriptions eliminates that burden. For a flat $69.95 per month, our Patient Advocates handle every step of your enrollment, from initial application through ongoing refill coordination and re-certification.

Pharmacy Price Comparison

Pharmacy(With Coupon)PrIce (30-Day)*You Save W/ Us
Walgreens

~$1,150

Save ~$1,080/mo

CVS Pharmacy

~$1,200

Save ~$1,130/mo

Walmart 

~$950

Save ~$880/mo

Costco

~$920

Save ~$850/mo

Specialty Pharmacy

~$1,000

Save ~$930/mo

*Just a heads-up — retail prices are estimates based on public data and vary by pharmacy. AffordMyPrescriptions Advocacy Service bypasses this by using drug manufacturer programs to secure your medication directly at no cost or retail price.

Our Pricing:

$69.95 Per month

1 Medications

$79.95 Per Month

2 Medications

$89.95 Per Month

3 Medications

$99.95 Per Month

4+ Medications

Why choose us For Your Veltassa Prescription Program?

The Patient Assistance Program is free to apply for and provides Veltassa at no medication cost if approved. Our $69.95/month service covers full advocacy.

Enroll

Complete a simple eligibility form so our team can determine if you may qualify for medication assistance programs.

We Advocate

Our specialists help gather documentation, complete applications, and coordinate with program providers.

Receive Medication

Once approved, you may receive your medication through the assistance program while we help manage ongoing paperwork and renewals.

Discount Coupons vs. Patient Assistance Programs

Many patients try discount cards first. Here’s why the Patient Assistance Program through AffordMyPrescriptions is the better long-term solution for Veltassa:

Limitations of Coupons

  • Prices fluctuate — savings aren’t guaranteed month-to-month
  • Copay accumulators may prevent savings from counting toward deductible
  • Coupon cards expire and require constant renewal
  • Still $900–$1,200 per month even with the best discount

  • Can’t be used with Medicare, Medicaid, or government insurance

Advantages of PAP Through Us

  • Fixed $69.95/month — never changes regardless of retail price
  • No expiration — continuous access as long as you qualify
  • Medication supplied directly through the assistance program
  • We manage all paperwork, refills, and annual renewals
  • If denied, we explore alternative savings on your behalf

DO YOU QUALIFY?

Eligibility is generally determined by annual household income and insurance status. Most programs follow guidelines that include limits of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. Because requirements vary by program and household, we encourage you to contact AffordMyPrescriptions directly so we can review your specific situation and determine if you qualify for Veltassa assistance.

Not sure if you qualify?  Our pre-qualification check is completely free. If we can’t help, you won’t be charged.

Understanding Veltassa:

Veltassa (patiromer) is a once-daily oral non-absorbed polymer that binds potassium in the GI tract — particularly in the colon — and eliminates it in stool. It is used for chronic management of hyperkalemia, especially in patients on RAAS inhibitors (ACE inhibitors, ARBs, mineralocorticoid receptor antagonists) where dose reduction or discontinuation would compromise heart failure or CKD management.

How Veltassa Works:

Patiromer is a non-absorbed polymer that treats hyperkalemia—a dangerous condition common in patients with CKD, heart failure, or those using RAAS inhibitors. Working primarily in the colon where potassium levels are higher, it binds potassium in exchange for calcium, allowing the potassium to be eliminated safely through stool. This lowering of serum potassium occurs over a period of seven hours to several days. By managing potassium levels chronically, it enables patients to stay on critical, guideline-directed heart and kidney medications that they would otherwise have to stop.

Form and use:

Veltassa is an oral powder taken once daily, with or without food, by mixing a packet with one-third of a cup of water or selective juices like apple or cranberry. Treatment begins at 8.4 g/day and can be adjusted weekly in 8.4 g steps up to a maximum dose of 25.2 g/day to keep serum potassium within a target range. Crucially, Veltassa must be taken at least 3 hours before or 3 hours after any other oral medications. This separation is vital because the drug can bind to other medications in the GI tract and reduce their absorption.

Generic availability:

As of 2026, there is no generic version of Veltassa available in the United States. Other options for managing chronic hyperkalemia include sodium zirconium cyclosilicate (Lokelma), which is a faster-acting brand-name alternative, as well as dietary changes and loop diuretics. While the older drug sodium polystyrene sulfonate (Kayexalate) is available as a cheaper generic, it is generally avoided for chronic outpatient use due to gastrointestinal side effects and the risk of intestinal necrosis.

Warnings:

Veltassa carries specific warnings regarding the worsening of gastrointestinal motility, meaning it should be avoided by patients with severe constipation, bowel obstructions, or post-surgical motility issues. It can lower absorption of other oral drugs, requiring a strict 3-hour administration buffer. Additionally, it can cause hypomagnesemia, which requires monitoring and potential supplementation of serum magnesium levels. Rare hypersensitivity reactions are also a noted risk.

FAQ (Frequently Asked Questions)

How Much Does Veltassa Cost Without Insurance?

Veltassa costs approximately $900–$1,200 per 30-day supply. Through AffordMyPrescriptions, qualifying patients receive Veltassa at no medication cost — our $69.95 monthly fee covers full advocacy and program management.

ACE inhibitors, ARBs, and mineralocorticoid receptor antagonists provide important cardiovascular and renal protection in heart failure and CKD. Reducing or discontinuing them because of hyperkalemia worsens long-term outcomes. Veltassa lowers potassium to allow continued guideline-directed doses of RAAS inhibitors — preserving their long-term benefits. This is especially important in heart failure with reduced ejection fraction and in proteinuric CKD.

Both are newer oral potassium binders. Veltassa (patiromer) — calcium-exchange polymer; once-daily dosing; primarily binds K+ in the colon; takes 7+ hours to lower serum K+. Lokelma (sodium zirconium cyclosilicate) — sodium/hydrogen-exchange zirconium silicate; faster acting (hours); given 10 g three times daily for emergent hyperkalemia or daily for maintenance; contains sodium load (a concern in heart failure patients). Choice depends on rapidity needed, sodium tolerance, and insurance coverage.

Veltassa is a charged polymer that can bind other medications in the GI tract — reducing their absorption. Take other oral medications either at least 3 hours BEFORE Veltassa or at least 3 hours AFTER Veltassa. This is especially important for medications with narrow therapeutic windows or where reduced absorption could be clinically significant.

Discuss with your prescriber. Veltassa allows more dietary flexibility regarding potassium-rich foods, but extreme intake may still overwhelm even high-dose Veltassa. Most patients on Veltassa can liberalize their diet somewhat compared with strict low-potassium diet, but should still avoid potassium supplements and very high-potassium foods (salt substitutes containing KCl, large quantities of certain fruits and vegetables) without checking labs first.

Yes. Medicare Part D beneficiaries can typically qualify, especially if you face specialty-tier copays. The manufacturer’s commercial copay savings program is reserved for commercially insured patients only — but the underlying PAP supports Medicare patients who meet income criteria.

If denied, we explore alternatives — switching to Lokelma (sodium zirconium cyclosilicate) with its own PAP, considering generic sodium polystyrene sulfonate for limited use, dietary potassium restriction with close monitoring, the manufacturer’s copay program for commercially insured patients, or independent foundations such as the American Kidney Fund, National Kidney Foundation, PAN Foundation, or HealthWell Foundation. If we cannot find a path, you won’t be charged our service fee.

Take Control of Your Medication Costs

If you are struggling with the high cost of Veltassa, our team may be able to help you access assistance programs designed to make brand specialty hyperkalemia therapy affordable. Check your eligibility today.

Submit Enrollment Form

Start free by filling out a simple online form.

Receive Welcome Call

Our specialist will contact you for a quick welcome call.

We Manage The Process

Our team handles everything, so you can focus on your health.

Receive Welcome Call

We Manage The Process